February 2024 Publications & Media Appearances
See the fascinating research and media interviews that our UMN Neurology faculty have been involved with in the month of February.
Publications
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA Randomized Clinical Trial, Investigators including Benjamin Miller
In: JAMA
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection, Gregory W. Albers, Mouhammad Jumaa, Barbara Purdon, Syed F. Zaidi, Christopher Streib for the TIMELESS Investigators
In: New England Journal of Medicine
Post Cardiac Arrest Care in the Cardiac Intensive Care Unit, Daniel Gonzalez, Garima Dahiya, Pornthira Mutirangura, Tesfatsiyon Ergando, Gregory Mello, Rahul Singh, Oladi Bentho, Andrea M. Elliott
In: Current Cardiology Reports
New-onset as opposed to established atrial fibrillation as a risk factor for incident stroke, Hassan Aboul-Nour, Ammar Jumah, Lonni Schultz, Muhammad Affan, Karam Gagi, Omar Choudhury, Megan Brady, Dawn Scozzari, Fadi Nahab, Daniel J. Miller, Stephan A. Mayer
In: Clinical Neurology and Neurosurgery
Paradoxical Modulation of STN β-Band Activity with Medication Compared to Deep Brain Stimulation, Meghan Hill, Luke Johnson, Jing Wang, David Escobar Sanabria, Rémi Patriat, Scott Cooper, Michael Park, Noam Harel, Jerrold Vitek, Joshua Aman
In: Clinical Neurology and Neurosurgery
Abstract
Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study, Investigators including Muhammad Affan, Omair Lodhi
In: Stroke
Commentary
Tenecteplase for Acute Ischemic Stroke Thrombolysis: Practical Considerations and Real-World Implementation, Christopher Streib
In: Neurology Clinical Practice
Media Appearances
Michael Howell in Medindia: “New Guidelines for Treating REM Sleep Behavior Disorder”
Peter Kang in Latin Business Today: “Limb-Girdle Muscular Dystrophy Scientific Leaders - Together With the FDA - Will Come Together for a Drug Development Workshop on February 8, 2024”
